Trial site
Barcelona
- 31running trials
- 39closed trials
The trials here
What the 70 trials at this site are about, from their registry records.
- Conditions
- Lung cancer12 trials
- Colorectal cancer8 trials
- Chronic myeloid leukaemia6 trials
- Melanoma6 trials
- Prostate cancer5 trials
- Acute myeloid leukaemia4 trials
- Childhood cancers4 trials
- Coronary artery disease4 trials
- Familial hypercholesterolaemia4 trials
- Gastric and oesophageal cancer4 trials
- Head and neck cancer4 trials
- High blood pressure4 trials
- and 34 more
- Phase
- Phase 322 trials
- Phase 118 trials
- Phase 216 trials
- Phase 1/27 trials
- Phase 43 trials
- Phase 2/32 trials
- Status
- Completed21 trials
- Active, not recruiting19 trials
- Terminated18 trials
- Recruiting12 trials
- Lead sponsor
- Novartis Pharmaceuticals70 trials
Running trials
Recruiting
Recruiting
A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Recruiting
Active, not recruiting
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Recruiting
Recruiting
Recruiting
Active, not recruiting
An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
Active, not recruiting
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
Active, not recruiting
Active, not recruiting
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer2 recruiting
- Aortic stenosis1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- IgA nephropathy1 recruiting
- Lung cancer1 recruiting
- Multiple sclerosis1 recruiting
- Pancreatic cancer1 recruiting
- Psoriasis1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Terminated
Terminated
Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants
Completed
Completed
Completed
Terminated
Terminated
Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension
Completed
Terminated
Completed
Terminated
Completed
Completed
Terminated
Completed
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
Terminated
Phase Ib Study of Select Drug Combinations in Patients With Lower Risk MDS
Terminated
Safety and Preliminary Efficacy of JBH492 Monotherapy in Patients With CLL and NHL
Terminated
Terminated
Completed
Terminated
A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab
Completed
Terminated
Terminated
Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
Completed
Completed
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
Completed
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
Completed
Completed
Terminated
Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Terminated
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
Terminated
Terminated
Completed
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Completed
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Site data: ClinicalTrials.govUpdated 17 Nov 2026